GJD3: A Protein Targeted for Pain, Neurodegenerative Diseases and Autoimmune Illnesses

Target Name: GJD3

NCBI ID: G125111

GJD3

GJD3: A Protein Targeted for Pain, Neurodegenerative Diseases and Autoimmune Illnesses

GJD3 (GJC1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a key role in cellular signaling.

GJD3 is known for its role in the regulation of pain perception and neurotransmitter release. It is expressed in the central nervous system and is involved in the development of pain sensitivity, as well as in the regulation of neurotransmitter release and sensitivity to pain.

GJD3 has also been shown to be involved in the regulation of inflammation and immune responses. It is expressed in the immune cells and is involved in the regulation of inflammation and the production of pro-inflammatory cytokines.

GJD3 is a potential drug target for various diseases, including pain, neurodegenerative diseases, and autoimmune diseases. Its role in these diseases makes it an attractive target for drug development, with potential therapeutic applications in a range of therapeutic areas, including pain management, neurodegenerative diseases, and immunology.

GJD3 is also a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Its expression and function make it a useful tool for the diagnosis and monitoring of these diseases.

In conclusion, GJD3 is a protein that is expressed in various tissues of the body and is involved in the regulation of pain perception, neurotransmission, and inflammation. Its potential as a drug target and biomarker makes it an attractive target for further research and development in the fields of pain management, neurodegenerative diseases, and immunology.

Protein Name: Gap Junction Protein Delta 3

Functions: One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell

The "GJD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GJD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets